StemoniX is setting a new standard for stem cell technologies to make micro-organs biological relevant, and providing their IPS-based platforms to pharmaceutical and research institutions to test for drug toxicity and efficacy.

IPO NASDAQ (VYNT)

http://stemonix.com/